EZHIP线:?

Afraah Cassim1, Matthew D Dun2, David Gallego-Ortega3

  • 1Cancer Epigenetic Biology and Therapeutics Laboratory, Children's Cancer Institute, Lowy Cancer Centre, Kensington, New South Wales, Australia; School of Biomedical Engineering, Faculty of Engineering and IT, University of Technology Sydney, New South Wales, Australia.

Trends in cancer
|September 29, 2024
PubMed
概括

在扩散的中线质瘤 (DMG) 中增强质抑制蛋白 (EZHIP) 异常表达镜像基因组H3 K27M突变. EZHIP和H3K27M都抑制PRC2,影响表观基因组景观,并为DMG提供潜在的治疗点.